[1] 麻广宇, 刘家金, 徐白萱, 等.  11C-乙酸盐PET/CT显像在中、高分化肝细胞肝癌复发与转移监测中的应用研究[J]. 国际放射医学核医学杂志, 2018, 42(4): 312-316.   doi: 10.3760/cma.j.issn.1673-4114.2018.04.004
Ma GY, Liu JJ, Xu BX, et al.  Application of 11C-acetate PET/CT imaging in the detection of recurrence and metastasis of hepatocellular carcinoma with intermediate and high differentiation[J]. Int J Radiat Med Nucl Med, 2018, 42(4): 312-316.   doi: 10.3760/cma.j.issn.1673-4114.2018.04.004
[2] Anwar H, Sachpekidis C, Winkler J, et al.  Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab[J]. Eur J Nucl Med Mol Imaging, 2018, 45(3): 376-383.   doi: 10.1007/s00259-017-3870-6
[3] Ming M, Wang ZG, Li DC, et al.  The applications of corrected standardized uptake values in the diagnosis of peripheral lung lesions[J]. Medicine (Baltimore), 2015, 94(6): e531-.   doi: 10.1097/MD.0000000000000531
[4] Basu S, Nair N.  Unusually elevated liver radioactivity on 18F-FDG PET in hodgkin's diseasehepatic 'Superscan'[J]. Clin Nucl Med, 2004, 29(10): 626-628.   doi: 10.1097/00003072-200410000-00005
[5] 刘国兵, 李艳丽, 胡鹏程, 等.  PET/CT显像中肝脏 18F-FDG摄取的影响因素[J]. 中华核医学与分子影像杂志, 2015, 35(6): 506-508.   doi: 10.3760/cma.j.issn.2095-2848.2015.06.022
Liu GB, Li YL, Hu PC, et al.  Factors affecting liver uptake of 18F-FDG on PET/CT imaging[J]. Chin J Nucl Med Mol Imaging, 2015, 35(6): 506-508.   doi: 10.3760/cma.j.issn.2095-2848.2015.06.022
[6] 呼岩, 刘国兵, 李艳丽, 等.  血糖及糖代谢相关因素对肝脏摄取18F-FDG的影响[J]. 中华核医学与分子影像杂志, 2017, 37(8): 470-474.   doi: 10.3760/cma.j.issn.2095-2848.2017.08.005
Hu Y, Liu GB, Li YL, et al.  Combined impacts of blood glucose level and glucose metabolism-related factors on liver 18F-FDG uptake[J]. Chin J Nucl Med Mol Imaging, 2017, 37(8): 470-474.   doi: 10.3760/cma.j.issn.2095-2848.2017.08.005
[7] Bural GG, Torigian DA, Burke A, et al.  Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept[J]. Mol Imaging Biol, 2010, 12(3): 233-239.   doi: 10.1007/s11307-009-0258-4
[8] Civelek A, Rana A, Malayeri A, et al.  PET-MRI derived 18F-FDG liver SUV metrics: effects of Hepatic Steatosis and comparison with PET-CT[J]. J Nucl Med, 2017, 58(Suppl 1): S455-.
[9] Manca C, Claudin M, Belle A, et al.  FDG PET/CT in type I glycogen storage disease[J]. Clin Nucl Med, 2016, 41(4): e200-e201.   doi: 10.1097/RLU.0000000000001103
[10] Fu ZL, Liu M, Chen XQ, et al.  Diffuse 18F-FDG avidity in liver associated with X-linked protoporphyria on PET/CT[J]. Clin Nucl Med, 2018, 43(8): 617-618.   doi: 10.1097/RLU.0000000000002159
[11] Huo L, Zheng YJ, Li F.  Diffuse hepatic FDG activity from nonmalignant etiologies[J]. Clin Nucl Med, 2015, 40(7): 589-591.   doi: 10.1097/RLU.0000000000000723
[12] 刘国兵, 李艳丽, 胡鹏程, 等.  肝功能指标及慢性肝炎病毒感染状态对肝脏摄取18F-FDG的影响[J]. 中华核医学与分子影像杂志, 2015, 35(4): 254-257.   doi: 10.3760/cma.j.issn.2095-2848.2015.04.004
Liu GB, Li YL, Hu PC, et al.  Impacts of infection status of hepatitis viruses and biochemical parameters of liver function on 18F-FDG uptake by the liver[J]. Chin J Nucl Med Mol Imaging, 2015, 35(4): 254-257.   doi: 10.3760/cma.j.issn.2095-2848.2015.04.004
[13] Salas JR, Chen BY, Wong A, et al.  Noninvasive imaging of drug-induced liver injury with 18F-DFA PET[J]. J Nucl Med, 2018, 59(8): 1308-1315.   doi: 10.2967/jnumed.117.206961
[14] Ceriani L, Suriano S, Ruberto T, et al.  18F-FDG uptake changes in liver and mediastinum during chemotherapy in patients with diffuse large B-cell lymphoma[J]. Clin Nucl Med, 2012, 37(10): 949-952.   doi: 10.1097/RLU.0b013e318263831d
[15] Wong SSM, Yuen HY, Ahuja AT.  Hepatic tuberculosis: a rare cause of fluorodeoxyglucose hepatic superscan with background suppression on positron emission tomography[J]. Singapore Med J, 2014, 55(7): e101-e103.   doi: 10.11622/smedj.2013237
[16] Zhou WY, Zhao JH, Xing Y, et al.  Diffuse hepatic amebiasis detected by FDG PET/CT[J]. Clin Nucl Med, 2015, 40(2): e167-e170.   doi: 10.1097/RLU.0000000000000605
[17] Tichelaar V, Gemmel F, de Rhoter W, et al.  FDG hepatic superscan caused by massive breast cancer invasion[J]. Clin Nucl Med, 2009, 34(10): 716-718.   doi: 10.1097/RLU.0b013e3181b53f43
[18] Muteganya R, Karfis I, Artigas C, et al.  Unusual diffuse liver 18F-FDG uptake in melanoma patient treated by ipilimumab[J]. Hell J Nucl Med, 2017, 20(2): 179-181.   doi: 10.1967/s002449910562
[19] Zhang XY, Chen XY, Zhang GQ, et al.  Diffuse liver metastasis from nasopharyngeal carcinoma found by 18F-FDG PET/CT scans[J]. Clin Nucl Med, 2018, 43(10): e374-e375.   doi: 10.1097/RLU.0000000000002211
[20] Caccamo D, Pervez NK, Marchevsky A.  Primary lymphoma of theliver in the acquired immunodeficiency syndrome[J]. Arch Pathol LabMed, 1986, 110(6): 553-555.
[21] Yang GJ, Nie P, Wang ZG, et al.  18F-FDG hepatic superscan caused by a non-germinal center subtype of diffuse large B-cell lymphoma[J]. Eur J Nucl Med Mol Imaging, 2016, 43(10): 1928-.   doi: 10.1007/s00259-016-3399-0
[22] 汤泊, 李天女, 丁重阳.  原发性肝脏淋巴瘤的18F-FDG PET-CT表现及临床分析[J]. 中国实验血液学杂志, 2018, 26(4): 1062-1066.   doi: 10.7534/j.issn.1009-2137.2018.04.020
Tang B, Li TN, Ding CY.  18F-FDG PET-CT manifestation and clinical analysis of primary hepatic lymphoma[J]. J Exp Hematol, 2018, 26(4): 1062-1066.   doi: 10.7534/j.issn.1009-2137.2018.04.020
[23] Mahajan S, Kalra S, Chawla M.  Detection of diffuse infiltrative primary hepatic lymphoma on FDG PET-CT: hallmarks of hepatic superscan[J]. World J Nucl Med, 2016, 15(2): 142-144.   doi: 10.4103/1450-1147.167581
[24] Kaneko K, Nishie A, Arima F.  A case of diffuse-type primary hepatic lymphoma mimicking diffuse hepatocellular carcinoma[J]. Ann Nucl Med, 2011, 25(4): 303-307.   doi: 10.1007/s12149-010-0460-0
[25]

Cho MW, Chin BB. 18F-FDG PET/CT findings in hepatosplenic Gamma-Delta T-cell lymphoma: case reports and review of the literature[J/OL]. Am J Nucl Med Mol Imaging, 2018, 8(2): 137−142[2019-06-13]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944829.
[26] Liu ET, Wang SY, Lai PL, et al.  "Hepatic Superscan" in a patient with hepatosplenic alphabeta T-cell lymphoma 18F-FDG PET/CT findings[J]. Clin Nucl Med, 2018, 43(8): 595-598.   doi: 10.1097/RLU.0000000000002134
[27]

Patel KJ, Latif SU, de Calaca WM. An unusual presentation of precursor T cell lymphoblastic leukemia/lymphoma with cholestatic jaundice: case report[J/OL]. J Hematol Oncol, 2009, 2: 12[2019-06-13]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663564. DOI: 10.1186/1756-8722-2-12.
[28] Tan YL, Yang XH, Dong CN, et al.  Diffuse hepatic epithelioid hemangioendothelioma with multiple splenic metastasis and delayed multifocal bone metastasis after liver transplantation on FDG PET/CT images: a case report[J]. Medicine(Baltimore), 2018, 97(22): e10728-.   doi: 10.1097/MD.0000000000010728
[29] Oe A, Habu D, Kawabe J, et al.  A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET[J]. Ann Nucl Med, 2005, 19(6): 519-521.   doi: 10.1007/BF02985582
[30] Son YM, Choi JY, Bak CH, et al.  18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma[J]. Korean J Radiol, 2011, 12(5): 634-637.   doi: 10.3348/kjr.2011.12.5.634
[31] Du BL, Li XN, Li N, et al.  18F-FDG hepatic superscan in a patient with chronic myeloid leukemia[J]. Clin Nucl Med, 2014, 39(9): 835-836.   doi: 10.1097/RLU.0000000000000413
[32] Taneja S, Achong DM.  Hepatic superscan on PET/CT due to Richter’s transformation of chronic lymphocytic leukemia[J]. Clin Nucl Med, 2010, 35(8): 644-645.   doi: 10.1097/RLU.0b013e3181e4dcad